PMGC Holdings ELAB
NASDAQ ELAB
$1.69 +0.11 (+6.96%)
At close: Nov 10, 2026 · 4:00 PM EST

PMGC Holdings (ELAB) Current Deferred Revenue (2022 - 2024)

Updated

Analysis

PMGC Holdings (ELAB) Current Deferred Revenue (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 PMGC Holdings 824,128.53 -47.54 Mn 385,691.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 39.58 Mn
Jun 30, 2024 24.31 Mn
Mar 31, 2024 35.15 Mn
Dec 31, 2023 36.69 Mn
Sep 30, 2023 54.85 Mn
Dec 31, 2022 10.17 Mn
API Access

PMGC Holdings Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ELAB&period=max&api_key=YOUR_API_KEY